Supplementary Methods
Polymer-coated iron oxide nanoparticle synthesis: Iron oxide nanoparticles were synthesized through a base-initiated co-precipitation of two iron salts, as adapted from Lee, et al 1 . with relative iron concentrations to dictate nanoparticle size guided by the work of Zhu, et al 2 . Briefly, the process was undertaken by dissolving iron (III) chloride hexahydrate and iron (II) chloride (Sigma) tetrahydrate in a 2:1 molar ratio in deoxygenated water in a nitrogen atmosphere. Then, poly(TMSMA-r-PEGDMA) was added at a 1:4 w/w ratio to the amount of iron (III) chloride and allowed to mix under nitrogen thoroughly. After mixing for at least 20 minutes to allow silane coordination with iron molecules, triethylamine (Sigma) was added in a 1:2 volume/volume ratio to the water solution as a buffered base to initiate nanoparticle crystallization. Crystallization occurred instantaneously, and the solution was bubbled vigorously under nitrogen to ensure adequate mixing for five minutes. The solution was then allowed to settle on a neodymium rare earth magnet (1.5" diameter, 0.125" thickness, K&J Magnetics, Inc.) until all particles collected at the bottom of the beaker. The supernatant was removed and the remaining particles mixed thoroughly with deoxygenated water to remove free polymer and base. This process was repeated two more times before finally resuspending the particles in a small amount of water (10 mL) to create a dense aqueous ferrofluid and sonicating the solution for fifteen minutes to separate large particle aggregates. The ferrofluid was left to settle over a magnet again for 24 hours to allow any remaining large particles to drop out of solution, leaving behind a stable, nanoparticulate, aqueous ferrofluid. The supernatant was then collected and heated at 80 °C for one hour to promote cross-linking of the coordinated polymer chains to stabilize the polymer shell. Finally, this solution was centrifuged at 3800rpm for 15 minutes to remove any remaining 3 aggregates resulting in polymer-coated iron oxide nanoparticles and stored at 4 °C until further use.
Iron oxide functionalized magnetic microrod fabrication: Ferrofluid was added in a 1:1 volume ratio to PEG-DMA (M N 750, Sigma Aldrich) and vortexed thoroughly. The photo-initiator 2,2-dimethoxy-2-phenylacetophenone (DMPA, Sigma Aldrich) was then solubilized in the crosslinking agent 1-vinyl-2-pyrrolidone (1V2P, Sigma Aldrich) into a working solution of 100mg per 1mL and added to the PEG-DMA mixture at a 15% volume/volume ratio and vortexed for 60 seconds. The photo-initiator was freshly prepared into a working solution before each round of fabrication and vortexed until completely dissolved.
The solution was then brought into the on-site cleanroom facility (Biomedical Micro-and Nanofabrication Core facility, UCSF) for wafer coating and microfabrication. Three-inch silicon wafers (Addison Engineering) were cleaned in a piranha bath (3:1, H 2 SO 4 :H 2 O 2 ) for 2 hours then rinsed three times in deionized water and dipped in acetone, methanol, and isopropanol for 5 seconds each then baked on a hotplate at 200 °C for at least 1 minute. Wafers were rinsed with isopropanol in the clean room and dried with a nitrogen gun immediately before being placed on the spin coater and depositing 750 mL of the precursor solution. The wafer was then spun at 350 rpm at an acceleration of 100 rpm/s for 10 seconds followed by 20 seconds at 500 rpm at an acceleration of 200 rpm/s to achieve a hydrogel layer desired thickness of 15 mm as confirmed through profilometery after cross-linking (XP-2, Ambios). The wafer was exposed to a 405nm
UV light source on a Karl Suss MJB3 mask aligner for 180 seconds at a power of 8mW/cm 2 through a chrome mask (Advance Reproductions Corporation) with an array of rectangles measuring 100mm x 15mm separated from each other by a spacing of 150mm on all sides. The mask aligner was operated in "high performance" mode to use positive pressure to ensure 4 maximum proximity of the coated wafer to the mask. After exposure, the wafer was placed in deionized water and soaked for at least 3 minutes with occasional minor agitation until most of the uncrosslinked hydrogel had dissolved. The wafer was then gently sprayed with isopropanol and dried with a nitrogen gun. The magnetic microstructures were then harvested by soaking in 70% ethanol and carefully scraping them off the wafer surface using a cell scraper. Lastly, the collected microrods were centrifuged and resuspended in a small volume of water for incorporation into imaging and remote 3D manipulation experiments. A hemacytometer was used to count the microstructures in order to titrate quantities for imaging studies. 
Supplementary Figures

Supplementary Discussion
Polymer surfaces have been well-studied to direct cell organization or growth in a tissue culture setting 3-6 , but the two-dimensional limitation of these technologies limits their physiological relevance. The use of 3D polymer scaffolds has sought to address this challenge, but the recapitulation of complex or microscale geometry to mimic native tissue matrices in a 6 controlled fashion is complicated by thermodynamically driven polymerization processes that can be difficult to minutely dictate.
The prospect of using non-invasive techniques to align and organize a discretized polymeric scaffold after implantation in the target tissue opens the door for new therapeutic potentials.
Although here we only show relatively simple linear alignment from a uniform magnetic field, more complex patterning could conceivably be achieved using more complex magnetic systems.
Additionally, we have studied the incorporation of growth factors or chemotactic molecules in the polymer matrix that could be co-introduced with the iron oxide inclusions to promote cell interaction with the aligned matrix, creating mechanochemical gradients for tissue regeneration instruction. For physiologic implementation, powerful magnetic fields will be needed to effect alignment of magnetized microstructures with significant tissue penetration, but the use of electromagnetically driven arrays to generate focused, defined fields would diminish this limitation. Lastly, it may be important to study the effect of strong, rapidly switching magnetic fields, such as those encountered in clinical MRI scanners to determine if this therapeutic strategy would be compatible with any radiographic imaging needs of the patient.
In therapeutic applications of discrete polymer microstructures for tissue engineering, which we have previously described 7-9 , it is often desirable to achieve precise and local microstructure delivery to affect only targeted regions of the tissue. In the setting of cardiac applications, for example, we have previously studied injections of as few as 6.5x10 4 microstructures into the millimeter-scale infarct zone. In order to assess the viability of MRI localization and tracking of injectable polymer microstructures, we set out to demonstrate that we could achieve sufficient spatial resolution and sensitivity to identify appropriately labeled microstructures over the complete implantation lifetime using this imaging technology.
Based on protocols adapted to develop the iron oxide nanoparticles, it could be estimated that the average iron oxide nanoparticle core size is approximately 15nm in diameter 27 . From this, the mass of each nanoparticle could be estimated by assuming a uniform sphere of volume 1.8 x 10 -18 ml and a density of 5.24 g/ml. This amounts to 9.3 x 10 -18 g/nanoparticle. Assuming our measured iron capacity per microrod of 0.6 and 2.4 pg, this amounts to approximately 65,000
and 260,000 nanoparticles per microrod, respectively, or 4.3 x 10 11 -1.7 x 10 12 nanoparticles/mL. However, this is further compounded by the fact that the nanoparticles are coated in silanized polymer chains that may protect them from contact with tissues and metabolic processing. It is not clear at what concentration the iron oxide nanoparticles would become toxic to tissues without further experimentation and toxicity studies, but at this concentration, they appear well-tolerated, as shown in Figure S3 .
The covalent inclusion of PFC ( Figure S2 ) into the microstructure matrix provides a similar stable tracking mechanism. However, an important additional consideration of using perfluorocarbons for implantable tissue engineering applications is their extreme hydrophobicity.
In addition to the logistical challenges of emulsifying these molecules in hydrophilic hydrogel precursor solutions, as described in this work, this hydrophobic nature may also affect the ability of cells to interact with polymeric microstructures at the sub-cellular level. Cell binding to polymer microstructures is likely dependent on adhesion to adsorbed proteins and the development of focal adhesion complexes 13, 14 . In some settings, this may be desirable to reduce tissue encapsulation of an implant, but for mechanically active structures, the intrusion of hydrophobic moieties may interfere with cell interaction and affect the integration of the microstructural cues. Again, by incorporating minimum amounts of fluorinated molecules into the polymer, this issue could be mitigated, but the effect on microstructure-cell interactivity will 8 need to be addressed. Alternatively, this challenge could be avoided by creating bilayered microstructures that are enveloped in a traditional hydrogel shell to mask the presence of the fluorine compounds, or designing more advanced micelle fluorine constructs that could conceal the fluorine molecules in their core while still integrating stably into the polymer matrix. The latter strategy could be an attractive solution to issues previously reported with micellar stability in physiologic environments by stabilizing the constructs into polymeric microstructures 15, 16 .
